Open access
Oct 2026
Early intensive combination lipid-lowering therapy in statin-naïve acute coronary syndrome: real-world attainment of lipid targets and analysis of therapeutic gaps
Inpatient initiation of high-intensity statin plus ezetimibe enabled over 80% of statin-naïve ACS patients to achieve stringent ESC/EAS LDL-C targets with an acceptable safety profile.
Y. Zhang, B. Yan, K. Kam et al.
· European Heart Journal · 0 citations